Published in Arch Immunol Ther Exp (Warsz) on June 28, 2015
The Role of Innate and Adaptive Immune Cells in the Immunopathogenesis of Chronic Obstructive Pulmonary Disease. Tuberc Respir Dis (Seoul) (2015) 0.76
Interstitial collagen turnover during airway remodeling in acute and chronic experimental asthma. Exp Ther Med (2016) 0.75
Remodeling in asthma and COPD-recent concepts. Lung India (2016) 0.75
HemoHIM, a herbal preparation, alleviates airway inflammation caused by cigarette smoke and lipopolysaccharide. Lab Anim Res (2017) 0.75
Inhaled corticosteroids do not reduce initial high activity of matrix metalloproteinase (MMP)-9 in exhaled breath condensates of children with asthma exacerbation: a proof of concept study. Cent Eur J Immunol (2016) 0.75
Functional Cooperation between KCa3.1 and TRPV4 Channels in Bronchial Smooth Muscle Cell Proliferation Associated with Chronic Asthma. Front Pharmacol (2017) 0.75
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2007) 47.86
The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy (2004) 13.16
Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest (2003) 12.56
International variation in the prevalence of COPD (the BOLD Study): a population-based prevalence study. Lancet (2007) 10.12
Matrix metalloproteinases: a review. Crit Rev Oral Biol Med (1993) 9.03
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest (2007) 6.56
Effect of bronchoconstriction on airway remodeling in asthma. N Engl J Med (2011) 6.05
Chronic obstructive pulmonary disease. Lancet (2012) 4.43
Regulation of matrix metalloproteinases: an overview. Mol Cell Biochem (2003) 4.33
Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med (2001) 3.59
Airway inflammation, basement membrane thickening and bronchial hyperresponsiveness in asthma. Thorax (2002) 3.58
Intermittent inhaled corticosteroids in infants with episodic wheezing. N Engl J Med (2006) 3.51
Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J (2006) 3.42
Epithelial repair mechanisms in the lung. Am J Physiol Lung Cell Mol Physiol (2010) 3.22
Matrix metalloproteinase-9 in lung remodeling. Am J Respir Cell Mol Biol (2003) 2.95
Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol (2000) 2.87
Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation (1999) 2.56
The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell (2000) 2.49
Manipulation of allergen-induced airway remodeling by treatment with anti-TGF-beta antibody: effect on the Smad signaling pathway. J Immunol (2005) 2.22
Epithelium dysfunction in asthma. J Allergy Clin Immunol (2007) 2.20
Regulation of matrix metalloproteinase activity in health and disease. FEBS J (2010) 1.88
Physiology and pathophysiology of matrix metalloproteases. Amino Acids (2010) 1.83
Increased release of matrix metalloproteinase-9 in the plasma of acute severe asthmatic patients. Clin Exp Allergy (2002) 1.82
Angiostatin-converting enzyme activities of human matrilysin (MMP-7) and gelatinase B/type IV collagenase (MMP-9). J Biol Chem (1997) 1.75
Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. Biochim Biophys Acta (2009) 1.73
Immunologic and inflammatory mechanisms that drive asthma progression to remodeling. J Allergy Clin Immunol (2008) 1.71
Polymorphism in matrix metalloproteinase gene promoters: implication in regulation of gene expression and susceptibility of various diseases. Matrix Biol (2000) 1.71
Airway remodeling contributes to the progressive loss of lung function in asthma: an overview. J Allergy Clin Immunol (2005) 1.65
Altered protein tyrosine phosphorylation in asthmatic bronchial epithelium. Eur Respir J (2005) 1.56
Reduced peribronchial fibrosis in allergen-challenged MMP-9-deficient mice. Am J Physiol Lung Cell Mol Physiol (2006) 1.46
Budesonide/formoterol effects on metalloproteolytic balance in TGFbeta-activated human lung fibroblasts. Respir Med (2009) 1.45
The bronchial epithelium as a key regulator of airway inflammation and remodelling in asthma. Clin Exp Allergy (1999) 1.43
Influence of matrix metalloproteinase genotype on cardiovascular disease susceptibility and outcome. Cardiovasc Res (2005) 1.37
Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells. J Cell Physiol (2007) 1.34
Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma. Respir Med (2004) 1.30
Asthma therapy and airway remodeling. J Allergy Clin Immunol (2007) 1.30
Matrix metalloproteinase-9 genotype influences large artery stiffness through effects on aortic gene and protein expression. Arterioscler Thromb Vasc Biol (2004) 1.23
The involvement of matrix metalloproteinase-9 in airway inflammation of patients with acute asthma. Clin Exp Allergy (2001) 1.22
Pharmacologic suppression of experimental abdominal aortic aneurysms: acomparison of doxycycline and four chemically modified tetracyclines. J Vasc Surg (1998) 1.21
Airway inflammation in childhood asthma. Am J Respir Crit Care Med (2003) 1.21
Enhanced bronchial expression of extracellular matrix proteins in chronic obstructive pulmonary disease. Am J Clin Pathol (2006) 1.17
A randomized controlled trial of inhaled corticosteroids (ICS) on markers of epithelial-mesenchymal transition (EMT) in large airway samples in COPD: an exploratory proof of concept study. Int J Chron Obstruct Pulmon Dis (2014) 1.13
Smoking cessation and bronchial epithelial remodelling in COPD: a cross-sectional study. Respir Res (2007) 1.13
Pharmacotherapy and airway remodelling in asthma? Thorax (2003) 1.11
Mechanisms of induction of airway smooth muscle hyperplasia by transforming growth factor-beta. Am J Physiol Lung Cell Mol Physiol (2007) 1.09
Airway smooth muscle in bronchial tone, inflammation, and remodeling: basic knowledge to clinical relevance. Am J Respir Crit Care Med (2007) 1.02
A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. J Vasc Surg (2002) 1.02
Remodelling of the upper airways in allergic rhinitis: is it a feature of the disease? Clin Exp Allergy (2003) 1.02
Matrix metalloproteinase activity in pediatric acute lung injury. Int J Med Sci (2008) 1.01
Inflammation in COPD: implications for management. Am J Med (2012) 1.00
Concentration of matrix metalloproteinase-9 in serum of patients with chronic obstructive pulmonary disease and a degree of airway obstruction and disease progression. J Physiol Pharmacol (2008) 0.98
Contribution of 92 kDa gelatinase/type IV collagenase in bronchial inflammation during status asthmaticus. Am J Respir Crit Care Med (1999) 0.97
Airway remodeling in asthma. Curr Opin Pulm Med (2005) 0.97
Renin-angiotensin system blockade: a novel therapeutic approach in chronic obstructive pulmonary disease. Clin Sci (Lond) (2012) 0.97
Cigarette smoke total particulate matter increases mucous secreting cell numbers in vitro: a potential model of goblet cell hyperplasia. Toxicol In Vitro (2010) 0.96
MMP-9 gene variants increase the risk for non-atopic asthma in children. Respir Res (2010) 0.95
Pathological airway remodelling in inflammation. Clin Respir J (2010) 0.95
Use of MMP-8 and MMP-9 to assess disease severity in children with viral lower respiratory tract infections. J Med Virol (2012) 0.95
MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD. Respir Med (2008) 0.94
Trends in the prevalence of asthma. Chest (2014) 0.93
Fibrotic response of tissue remodeling in COPD. Lung (2011) 0.92
Inhibition of experimental abdominal aortic aneurysm in a rat model by the angiotensin receptor blocker valsartan. Int J Mol Med (2008) 0.91
Genotypes in matrix metalloproteinase 9 are a risk factor for COPD. Int J Chron Obstruct Pulmon Dis (2006) 0.91
Airway wall remodelling: the influence of corticosteroids. Curr Opin Allergy Clin Immunol (2005) 0.91
Potential role of metalloproteinase inhibitors from radiation‑sterilized amnion dressings in the healing of venous leg ulcers. Mol Med Rep (2012) 0.90
Polymorphisms in matrix metalloproteinase-1, -9 and -12 genes and the risk of chronic obstructive pulmonary disease in a Korean population. Respiration (2010) 0.89
Functional polymorphism in the gelatinase B gene and asthma. Allergy (2000) 0.88
Expression of profibrotic mediators in small airways versus parenchyma after cigarette smoke exposure. Am J Respir Cell Mol Biol (2008) 0.88
Non-invasive markers of airway inflammation and remodeling in childhood asthma. Pediatr Allergy Immunol (2009) 0.88
Bronchoalveolar lavage MMP-9 and TIMP-1 in preschool wheezers and their relationship to persistent wheeze. Pediatr Res (2008) 0.86
DNA sequence variations of metalloproteinases: their role in asthma and COPD. Postgrad Med J (2007) 0.85
On the structure and chromosome location of the 72- and 92-kDa human type IV collagenase genes. Genomics (1991) 0.84
A brief history of asthma and its mechanisms to modern concepts of disease pathogenesis. Allergy Asthma Immunol Res (2010) 0.84
Mast cell-fibroblast interactions induce matrix metalloproteinase-9 release from fibroblasts: role for IgE-mediated mast cell activation. J Immunol (2008) 0.84
Association study of polymorphisms within matrix metalloproteinase 9 with bronchial asthma. Int J Immunogenet (2005) 0.84
Production of matrix metalloproteinases in human cultured mast cells: involvement of protein kinase C-mitogen activated protein kinase kinase-extracellular signal-regulated kinase pathway. Allergol Int (2006) 0.83
The direct inhibition of MMP-2 and MMP-9 by an enzyme alginogel: a possible mechanism of healing support for venous leg ulcers. J Wound Care (2014) 0.81
Prolonged Treatment with Inhaled Corticosteroids does not Normalize High Activity of Matrix Metalloproteinase-9 in Exhaled Breath Condensates of Children with Asthma. Arch Immunol Ther Exp (Warsz) (2015) 0.79
Neovastat (AE-941) inhibits the airway inflammation and hyperresponsiveness in a murine model of asthma. J Microbiol (2005) 0.78
A new synthetic matrix metalloproteinase inhibitor modulates both angiogenesis and urokinase type plasminogen activator activity. Angiogenesis (1998) 0.78
Matrix metalloproteinases in the aneurysm wall of patients treated with low-dose doxycycline. Vascular (2005) 0.78
Association of the MMP9 gene with childhood cedar pollen sensitization and pollinosis. J Hum Genet (2012) 0.77
Association between angiotensin-converting enzyme I/D polymorphism and asthma risk: a meta-analysis involving 11,897 subjects. J Asthma (2012) 0.76
Genetic risk factors of chronic venous leg ulceration: Can molecular screening aid in the prevention of chronic venous insufficiency complications? Mol Med Rep (2011) 0.76
Prolonged Treatment with Inhaled Corticosteroids does not Normalize High Activity of Matrix Metalloproteinase-9 in Exhaled Breath Condensates of Children with Asthma. Arch Immunol Ther Exp (Warsz) (2015) 0.79
Polymorphic Variants 279R and 668Q Augment Activity of Matrix Metalloproteinase-9 in Breath Condensates of Children with Asthma. Arch Immunol Ther Exp (Warsz) (2016) 0.75